Tony, H P
3 papers on CoChat
Most cited papers
- Verified
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
Emery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 1,104
- Verified
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
Burmester, G. R., Buttgereit, F., Bernasconi, C., Álvaro-Gracia, J. M., Castro, N., Dougados, M., Gabay, C., van Laar, J. M., Nebesky, J. M., Pethoe-Schramm, A., et al. (2020) · The Lancet
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 128
- Verified
Human regulatory T cells are selectively activated by low‐dose application of the CD28 superagonist TGN1412/TAB08
Tabares, P., Berr, S., Römer, P. S., Chuvpilo, S., Matskevich, A. A., Tyrsin, D., Fedotov, Y., Einsele, H., Tony, H., & Hünig, T. (2014) · European Journal of Immunology
T-cell and B-cell ImmunologyImmunotherapy and Immune Responses
Cited by 97
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free